Data from: A fusion protein’s weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein
Data files
Mar 17, 2026 version files 5.73 MB
-
Dryad_Repository_for_S164P_final_annotated.xlsx
2.88 MB
-
Dryad_Repository_for_S164P_final_no_formating.xlsx
2.81 MB
-
README.md
4.73 KB
-
Sequences_S164P_dryad.xlsx
29.48 KB
Abstract
Human parainfluenza viruses (HPIVs) cause significant respiratory illnesses including croup and pneumonia. HPIV infection begins with fusion of viral and host cell membranes, driven by the coordinated actions of the attachment (HN) and fusion (F) glycoproteins, which together form the fusion/entry complex. We have described fusion inhibitory peptides derived from the heptad repeat (HRC) domain of the F glycoprotein with potent antiviral activity against HPIV3 and other paramyxoviruses. These peptides inhibit fusion by binding to the transiently exposed N-terminal heptad repeat (HRN) segments of the F prehairpin intermediate and preventing the six-helix bundle (6HB) formation that is required for the membrane fusion process. We report viral variants that escape inhibition by an α/β-substituted HRC peptide of HPIV3 through an HN mutation that enhances HN’s activation of F, and a mutation in F’s HRN domain that destabilizes the 6HB. The F HRN domain bearing the alteration shows reduced α-helicity relative to the wildtype HRN and forms an assembly with the HRC domain that is destabilized relative to the wildtype 6HB. This viral variant is not resistant to an HRC-derived α-peptide inhibitor that forms a more stable 6HB relative to the HRC-derived α/β-peptide. The emergence of this variant suggests that improved inhibitor potency against HPIV3 could be achieved by increasing the stability of the α/β-peptide/HRN 6HB. The unique mutation in F that reduces sensitivity to inhibitor also compromises viral fitness in a human airway model and impairs viral infection, presumably as a result of diminished post-fusion state stability.
Dryad_Repository_for_S164P_final_annotated.xlsx
In Dryad_Repository_for_S164P_final_annotated.xlsx and Dryad_Repository_for_S164P_final_no_formating.xlsx, each tab contains raw data and is named according to the figure panels used in the manuscript: A fusion protein’s weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein. The first worksheet in each file describes the figures. The content for both files is the same: one contains formatting for readability, and the other does not.
Abbreviations:
- HN: hemagglutinin-neuraminidase protein
- F: fusion protein
- HA: uncleaved influenza hemagglutinin
- Parental: clinical isolate HPIV3 virus bearing the HN H552Q mutation used as the input virus for viral evolution.
- VI-8-EV: virus bearing the HN N556D and F S164P mutations originating from the α/β-VI-8-PEG4-Chol evolution. Number following the EV indicates allele frequency of S164P.
- S164P: A serine to proline mutation at residue 164 in the F protein within the n-terminal heptadic repeats.
- D216R: An aspartic acid to arginine HN mutation at position 216 that makes HN sialidase-deficient to maximize the HN-receptor contact and HN’s fusion promotion.
- H552Q: A histidine to glutamine HN mutation at residue 552 with enhanced F activation properties.
- T193A: A threonine to alanine HN mutation at position 193 that confers increased avidity.
- Lab-adapted HN and F: HPIV3 sequence derived from the consensus Wash/47885/57 strain
- Clinical isolate 1 HN and F: HPIV3 sequence derived from a patient and characterized in “Features of Circulating Parainfluenza Virus Required for Growth in Human Airway” https://doi.org/10.1128/mbio.00235-16
- nM: nanomolar
- DMSO: Dimethyl sulfoxide
- α/β-VI-8-PEG4-Chol: α/β-substituted HPIV3 fusion inhibitory peptide affixed to cholesterol with a PEG4 linker
- α-VIKI-PEG4-Chol: broad-spectrum HPIV3 fusion-inhibitory peptide affixed to cholesterol with a PEG4 linker
- α-VI-PEG4-Chol: progenitor HPIV3 fusion inhibitory peptide for α/β-VI-8-PEG4-Chol affixed to cholesterol with a PEG4 linker
- A.U.: arbitrary units for determining indirect fluorescence
- HRN S164P: HPIV3 HRN domain bearing S164P mutation
- Native HRN: parental HPIV3 HRN domain
- mDeg: millidegrees
- 103 deg cm2 dmol-1 res-1: unit for mean residue ellipticity
- nm: nanometers
- Native HRC: parental HPIV3 HRC domain
- Zanamivir: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid (4-GU-DANA), a sialic acid analog that interacts with the HPIV3 HN protein to block receptor engagement
- CI-1 HN H552Q: Clinical isolate HPIV3 virus bearing the HN H552Q mutation
- VI-8-EV-82: Clinical isolate HPIV3 virus bearing the HN H552Q and N556D mutations, as well as the F S164P mutation at 82% allele frequency
- VI-8-EV-95: Clinical isolate HPIV3 virus bearing the HN H552Q and N556D mutations, as well as the F S164P mutation at 95% allele frequency
- PFU: plaque-forming unit
- D216R: An aspartic acid to arginine HN mutation at residue 216 that makes HN sialidase-deficient to maximize the HN-receptor contact and HN’s fusion promotion.
Sequences_S164P_dryad.xlsx
Sequences_S164P_dryad.xlsx contains a list of each plasmid used in the manuscript: A fusion protein’s weak link: functional constraints revealed by inhibitory peptide interaction with the parainfluenza fusion protein
- HN: hemagglutinin-neuraminidase protein
- F: Fusion protein
- HA: Hemagglutinin
- D216R: An aspartic acid to arginine HN mutation at residue 216 that makes HN sialidase-deficient to maximize the HN-receptor contact and HN’s fusion promotion.
- T193A: A threonine to alanine HN mutation at residue 193 that confers increased avidity.
- H552Q: A histidine to glutamine HN mutation at residue 552 with enhanced F activation properties.
- Lab-adapted HN and F: HPIV3 sequence derived from the consensus Wash/47885/57 strain
- Clinical isolate 1 HN and F: HPIV3 sequence derived from a patient and characterized in “Features of Circulating Parainfluenza Virus Required for Growth in Human Airway” https://doi.org/10.1128/mbio.00235-16
- JS HN and F: HPIV3 lab-adapted viral sequence “The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3)” https://doi.org/10.1016/0168-1702(93)90014-e
